These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37540451)

  • 1. Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model.
    Levy DT; Cadham CJ; Yuan Z; Li Y; Gravely S; Cummings KM
    Can J Public Health; 2023 Dec; 114(6):992-1005. PubMed ID: 37540451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US Nicotine Vaping Product
    Levy DT; Sánchez-Romero LM; Travis N; Yuan Z; Li Y; Skolnick S; Jeon J; Tam J; Meza R
    Int J Environ Res Public Health; 2021 May; 18(9):. PubMed ID: 34063672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. England SimSmoke: the impact of nicotine vaping on smoking prevalence and smoking-attributable deaths in England.
    Levy DT; Sánchez-Romero LM; Li Y; Yuan Z; Travis N; Jarvis MJ; Brown J; McNeill A
    Addiction; 2021 May; 116(5):1196-1211. PubMed ID: 32949419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of awareness, ever-use and current use of nicotine vaping products (NVPs) among adult current smokers and ex-smokers in 14 countries with differing regulations on sales and marketing of NVPs: cross-sectional findings from the ITC Project.
    Gravely S; Driezen P; Ouimet J; Quah ACK; Cummings KM; Thompson ME; Boudreau C; Hammond D; McNeill A; Borland R; Thrasher JF; Edwards R; Omar M; Hitchman SC; Yong HH; Barrientos-Gutierrez T; Willemsen MC; Bianco E; Boado M; Goma FM; Seo HG; Nargis N; Jiang Y; Perez CA; Fong GT
    Addiction; 2019 Jun; 114(6):1060-1073. PubMed ID: 30681215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult smokers' discussions about vaping with health professionals and subsequent behavior change: a cohort study.
    Cho YJ; Thrasher JF; Gravely S; Alberg A; Borland R; Yong HH; Cummings KM; Hitchman SC; Fong GT
    Addiction; 2022 Nov; 117(11):2933-2942. PubMed ID: 35792058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Australia Smoking and Vaping Model: The Potential Impact of Increasing Access to Nicotine Vaping Products.
    Levy DT; Gartner C; Liber AC; Sánchez-Romero LM; Yuan Z; Li Y; Cummings KM; Borland R
    Nicotine Tob Res; 2023 Feb; 25(3):486-497. PubMed ID: 36073731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modeling approach to gauging the effects of nicotine vaping product use on cessation from cigarettes: what do we know, what do we need to know?
    Levy DT; Yuan Z; Li Y; Alberg AJ; Cummings KM
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):86-96. PubMed ID: 30548714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The smoking and vaping model, A user-friendly model for examining the country-specific impact of nicotine VAPING product use: application to Germany.
    Sánchez-Romero LM; Liber AC; Li Y; Yuan Z; Tam J; Travis N; Jeon J; Issabakhsh M; Meza R; Levy DT
    BMC Public Health; 2023 Nov; 23(1):2299. PubMed ID: 37990171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Noticing Nicotine Vaping Product Health Warning Labels, Harm Perceptions, and Use Among Adult Vapers, Current and Former Smokers. Findings From the 2018 ITC Four Country Smoking and Vaping Survey.
    Taylor E; Aleyan S; East K; Michael Cummings K; Thrasher JF; Fong GT; Quah ACK; Li G; Borland R; Hammond D; Hitchman SC
    Nicotine Tob Res; 2022 Jun; 24(7):1020-1027. PubMed ID: 34893915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Social Norms for Cigarette Smoking and Nicotine Vaping Product Use Predict Trying Nicotine Vaping Products and Attempts to Quit Cigarette Smoking Amongst Adult Smokers? Findings From the 2016-2020 International Tobacco Control Four Country Smoking and Vaping Surveys.
    Yong HH; Chow R; East K; Thrasher JF; Hitchman SC; Borland R; Cummings KM; Fong GT
    Nicotine Tob Res; 2023 Feb; 25(3):505-513. PubMed ID: 36082962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do users compare the costs between nicotine vaping products and cigarettes? Findings from the 2016-2020 International Tobacco Control United States surveys.
    He Y; Liber A; Driezen P; Thompson ME; Levy DT; Fong GT; Cummings KM; Shang C
    Addiction; 2024 May; 119(5):885-897. PubMed ID: 38186201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prices, use restrictions and electronic cigarette use-evidence from wave 1 (2016) US data of the ITC Four Country Smoking and Vaping Survey.
    Cheng KW; Chaloupka FJ; Shang C; Ngo A; Fong GT; Borland R; Heckman BW; Levy DT; Cummings KM
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):115-122. PubMed ID: 30690802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discussions between health professionals and smokers about nicotine vaping products: results from the 2016 ITC Four Country Smoking and Vaping Survey.
    Gravely S; Thrasher JF; Cummings KM; Ouimet J; McNeill A; Meng G; Lindblom EN; Loewen R; O'Connor RJ; Thompson ME; Hitchman SC; Hammond D; Heckman BW; Borland R; Yong HH; Elton-Marshall T; Bansal-Travers M; Gartner C; Fong GT
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):71-85. PubMed ID: 30548374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in norms towards the use of nicotine vaping products among adult smokers, former smokers and nicotine vaping product users: cross-sectional findings from the 2016 ITC Four Country Smoking and Vaping Survey.
    Aleyan S; East K; McNeill A; Cummings KM; Fong GT; Yong HH; Thrasher JF; Borland R; Hitchman SC
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):97-106. PubMed ID: 31062388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of nicotine vaping products used by participants in the 2016 ITC Four Country Smoking and Vaping Survey.
    O'Connor RJ; Fix BV; McNeill A; Goniewicz ML; Bansal-Travers M; Heckman BW; Cummings KM; Hitchman S; Borland R; Hammond D; Levy D; Gravely S; Fong GT
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):15-23. PubMed ID: 30701622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the implementation of a prescription only regulatory model for nicotine vaping products: A qualitative study on the experiences and views of healthcare professionals.
    Morphett K; Holland A; Ward S; Steadman KJ; Zwar NA; Gartner C
    Int J Drug Policy; 2024 Mar; 125():104353. PubMed ID: 38364356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health implications of vaping in the USA: the smoking and vaping simulation model.
    Levy DT; Tam J; Sanchez-Romero LM; Li Y; Yuan Z; Jeon J; Meza R
    Popul Health Metr; 2021 Apr; 19(1):19. PubMed ID: 33865410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine vaping product use, harm perception and policy support among pharmacy customers in Brisbane, Australia.
    Erku DA; Gartner CE; Tengphakwaen U; Morphett K; Steadman KJ
    Drug Alcohol Rev; 2019 Sep; 38(6):703-711. PubMed ID: 31486151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing Heated Tobacco Product Use Among Adult Cigarette Smokers and Nicotine Vaping Product Users in the 2018 ITC Four Country Smoking & Vaping Survey.
    Miller CR; Sutanto E; Smith DM; Hitchman SC; Gravely S; Yong HH; Borland R; O'Connor RJ; Cummings KM; Fong GT; Hyland A; Quah ACK; Goniewicz ML
    Nicotine Tob Res; 2022 Mar; 24(4):493-502. PubMed ID: 34669964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in responses to nicotine vaping product warnings and leaflets in England compared with Canada, the US and Australia: findings from the 2016-2018 ITC Four Country Smoking and Vaping Surveys.
    Taylor EV; East KA; McNeill A; Cummings M; Thrasher J; Fong GT; Quah ACK; McDermot M; Li G; Borland R; Hammond D; Aleyan S; Hitchman SC
    Tob Control; 2022 Jan; 31(1):107-111. PubMed ID: 33115961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.